AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
Inclusion Criteria:
Individuals must meet the following criteria to be eligible for study participation:
Exclusion Criteria:
Individuals must not meet any of the following criteria to be eligible for study participation:
Prior exposure to seladelpar
A medical condition other than PBC that, in the Investigator's opinion, would preclude full participation in the study
History of liver transplantation or actively listed for cadaveric or planned living donor transplant.
Decompensated cirrhosis
Evidence of portal vein thrombosis based on imaging at time of Screening by Doppler ultrasound or prior evidence by CT or MRI
Hospitalization for liver-related complication within 12 weeks of Screening
Laboratory parameters at Screening:
CP-C cirrhosis
History or presence of other concomitant liver diseases
GileadClinicalTrials@gilead.com1-833-445-3230 (GILEAD-0)
Phoenix, Arizona 85013, United States
Los Angeles, California 90027, United States
San Francisco, California 94109, United States
South San Francisco, California 94080, United States
Atlanta, Georgia 30309, United States
New Orleans, Louisiana 70112, United States
Rochester, Minnesota 14642, United States
Manhasset, New York 11030, United States
Hershey, Pennsylvania 17033, United States
Philadelphia, Pennsylvania 19104, United States
Dallas, Texas 75390, United States
Fairfax, Virginia 22031, United States
Newport News, Virginia 23602, United States
Queensland, Queensland 4102, Australia
Wuhan, 430030, China
Zhejiang, 310009, China
Prague, 128 08, Czechia
Montipellier, 34295, France
Ancona, 60020, Italy
Milan, 20142, Italy
Modena, 41126, Italy
Kaohsiung City, 83301, Taiwan
Gaziantep, 27630, Turkey (Türkiye)
Rize Merkez, 53020, Turkey (Türkiye)
Ipswich, IP4 5PD, United Kingdom